chr22-18918464-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016335.6(PRODH):c.1279G>A(p.Val427Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 4 hom., cov: 2)
Exomes 𝑓: 0.036 ( 394 hom. )
Failed GnomAD Quality Control
Consequence
PRODH
NM_016335.6 missense
NM_016335.6 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: 0.286
Publications
17 publications found
Genes affected
PRODH (HGNC:9453): (proline dehydrogenase 1) This gene encodes a mitochondrial protein that catalyzes the first step in proline degradation. Mutations in this gene are associated with hyperprolinemia type 1 and susceptibility to schizophrenia 4 (SCZD4). This gene is located on chromosome 22q11.21, a region which has also been associated with the contiguous gene deletion syndromes, DiGeorge and CATCH22. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2010]
PRODH Gene-Disease associations (from GenCC):
- hyperprolinemia type 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0030622482).
BP6
Variant 22-18918464-C-T is Benign according to our data. Variant chr22-18918464-C-T is described in ClinVar as Benign. ClinVar VariationId is 459909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0996 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRODH | NM_016335.6 | c.1279G>A | p.Val427Met | missense_variant | Exon 11 of 14 | ENST00000357068.11 | NP_057419.5 | |
| PRODH | NM_001195226.2 | c.955G>A | p.Val319Met | missense_variant | Exon 11 of 14 | NP_001182155.2 | ||
| PRODH | NM_001368250.2 | c.955G>A | p.Val319Met | missense_variant | Exon 11 of 14 | NP_001355179.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PRODH | ENST00000357068.11 | c.1279G>A | p.Val427Met | missense_variant | Exon 11 of 14 | 1 | NM_016335.6 | ENSP00000349577.6 | ||
| ENSG00000283809 | ENST00000638240.1 | c.513+7436C>T | intron_variant | Intron 4 of 5 | 5 | ENSP00000492446.1 |
Frequencies
GnomAD3 genomes AF: 0.0307 AC: 120AN: 3904Hom.: 4 Cov.: 2 show subpopulations
GnomAD3 genomes
AF:
AC:
120
AN:
3904
Hom.:
Cov.:
2
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0384 AC: 9422AN: 245360 AF XY: 0.0330 show subpopulations
GnomAD2 exomes
AF:
AC:
9422
AN:
245360
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0357 AC: 5726AN: 160352Hom.: 394 Cov.: 0 AF XY: 0.0331 AC XY: 2826AN XY: 85352 show subpopulations
GnomAD4 exome
AF:
AC:
5726
AN:
160352
Hom.:
Cov.:
0
AF XY:
AC XY:
2826
AN XY:
85352
show subpopulations
African (AFR)
AF:
AC:
529
AN:
7168
American (AMR)
AF:
AC:
729
AN:
8064
Ashkenazi Jewish (ASJ)
AF:
AC:
73
AN:
5226
East Asian (EAS)
AF:
AC:
1847
AN:
17838
South Asian (SAS)
AF:
AC:
240
AN:
21968
European-Finnish (FIN)
AF:
AC:
37
AN:
7384
Middle Eastern (MID)
AF:
AC:
15
AN:
856
European-Non Finnish (NFE)
AF:
AC:
1897
AN:
82340
Other (OTH)
AF:
AC:
359
AN:
9508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
205
411
616
822
1027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0302 AC: 118AN: 3912Hom.: 4 Cov.: 2 AF XY: 0.0329 AC XY: 59AN XY: 1796 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
118
AN:
3912
Hom.:
Cov.:
2
AF XY:
AC XY:
59
AN XY:
1796
show subpopulations
African (AFR)
AF:
AC:
48
AN:
1166
American (AMR)
AF:
AC:
24
AN:
472
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
78
East Asian (EAS)
AF:
AC:
30
AN:
344
South Asian (SAS)
AF:
AC:
1
AN:
262
European-Finnish (FIN)
AF:
AC:
0
AN:
162
Middle Eastern (MID)
AF:
AC:
0
AN:
42
European-Non Finnish (NFE)
AF:
AC:
13
AN:
1284
Other (OTH)
AF:
AC:
2
AN:
96
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
65
ALSPAC
AF:
AC:
71
ESP6500AA
AF:
AC:
350
ESP6500EA
AF:
AC:
125
ExAC
AF:
AC:
4393
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This variant is associated with the following publications: (PMID: 23462603, 15662599, 24842239, 22090377) -
Proline dehydrogenase deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;.;D;.
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
0.35
.;B;B;.
Vest4
MPC
0.30
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.